Carnosine Impurity 1 represents a related dipeptide species formed during carnosine synthesis or stress exposure. Its altered structure affects polarity and chromatographic retention. Researchers use it to validate impurity quantitation and confirm method accuracy. Applications include QC profiling, stability testing, and degradation-pathway assessment.
CAT No: Z10-101-180
CAS No:3339-73-9
Synonyms/Alias:3-(1,3-dioxoisoindolin-2-yl)propanoic acid
Carnosine Impurity 1 is a structurally related analogue of carnosine, a naturally occurring dipeptide found in muscle and brain tissues. As a synthetic impurity, it arises during the production or degradation of carnosine and is characterized by its modified peptide sequence or chemical alteration. The analytical significance of Carnosine Impurity 1 lies in its close resemblance to the parent compound, making it highly relevant for studies focused on peptide synthesis quality, degradation pathways, and the structural elucidation of related biomolecules. Its presence and characterization are crucial in ensuring the reliability and reproducibility of research involving carnosine and its derivatives.
Analytical method development: The availability of Carnosine Impurity 1 is essential for the development and validation of robust analytical methods, such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS), used to quantify carnosine and its impurities in research samples. By serving as a reference standard, it allows researchers to accurately identify and quantify trace levels of structurally similar byproducts, thereby supporting rigorous quality control and ensuring the specificity and sensitivity of analytical protocols.
Peptide synthesis optimization: In peptide chemistry, the presence of impurities like this analogue provides valuable insight into the efficiency and selectivity of synthetic routes. Researchers utilize Carnosine Impurity 1 to investigate side reactions and optimize reaction conditions during solid-phase or solution-phase peptide synthesis. Monitoring its formation and controlling its levels enables the refinement of synthetic strategies, ultimately leading to higher yield and purity of the target dipeptide.
Degradation pathway elucidation: The study of Carnosine Impurity 1 is instrumental in mapping the degradation pathways of carnosine under various environmental or experimental conditions. By tracking the formation of such impurities during storage, processing, or exposure to stress factors, scientists can better understand the stability profile of carnosine-based formulations. This knowledge informs the design of improved storage conditions as well as the development of more stable peptide derivatives for research applications.
Peptide characterization and structural analysis: The structural similarity between the impurity and the parent dipeptide makes Carnosine Impurity 1 a useful tool in the validation of analytical techniques designed to distinguish between closely related peptide species. Its use in comparative studies assists in refining methods for structural elucidation, such as tandem mass spectrometry or NMR spectroscopy, ensuring that researchers can confidently differentiate between target compounds and their analogues in complex mixtures.
Biochemical assay development: The inclusion of Carnosine Impurity 1 in biochemical assay development enables the assessment of assay selectivity and interference. By evaluating how the impurity interacts with assay components or detection reagents, researchers can identify and mitigate potential sources of analytical bias. This leads to more accurate quantification and interpretation of peptide activity, especially in studies where trace impurities may affect experimental outcomes.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More